The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Phase I study on patients with oxi refractory/intolerant KRAS mutant CRC

coloCan
coloCan CSN Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
announced this date by Calgary, Canada-based Oncolytics Biotech, which will consist of FOLFIRI (Leucovorin,5FU and Irinotecan)with this new thing called Reolysin (REO). For more info see www.prnewsire.com or
rttnews.com

Hope this helps someone
Like Care

Discussion Boards